Back to Results
First PageMeta Content
Pharmaceutical sciences / Pharmacy / Drug safety / Health in Canada / Pharmacology / Health Products and Food Branch / Pharmaceutical industry / Patient safety / Over-the-counter drug / Medicine / Health / Pharmaceuticals policy


Untitled Document This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It
Add to Reading List

Document Date: 2013-07-09 10:28:54


Open Document

File Size: 161,30 KB

Share Result on Facebook

City

Washington D.C. / /

Company

Drug Name Review / /

Country

Canada / /

/

Event

FDA Phase / /

Facility

Hospital Pharmacists / /

/

IndustryTerm

health product / pharmaceuticals / pharmaceutical industry / Chemical name / health products / veterinary drug products / natural health products / over-the-counter products / marketed health product / food / /

MedicalTreatment

immunization / medication errors / /

Organization

Health Products and Food Branch / Government of Canada / Government of Canada Web Standards / Canadian Medical Association / Public Health Agency of Canada / Partnerships Division / Veterinary Drugs Directorate / Products Directorate / U.S. Securities and Exchange Commission / Canadian Pharmacists Association / Marketed Health Products Directorate / Canadian Society of Hospital Pharmacists / /

Person

Lili Loorand-Stiver / /

/

Position

ond PM / C. Turner Director General / Minister of Health / trained chemist / /

Product

potassium chloride / Safe Medication / Haloperidol / dextrose / Review / /

PublishedMedium

the Drug Name Review / /

Technology

radiopharmaceuticals / /

SocialTag